Your browser doesn't support javascript.
loading
Skin blood flow changes in response to intradermal injection of bupivacaine and levobupivacaine, assessed by laser Doppler imaging.
Newton, D J; Burke, D; Khan, F; McLeod, G A; Belch, J J; McKenzie, M; Bannister, J.
Afiliação
  • Newton DJ; Section of Vascular Medicine and Biology, University Department of Medicine, Ninewells Hospital and Medical School, Dundee DD1 9SY, Scotland.
Reg Anesth Pain Med ; 25(6): 626-31, 2000.
Article em En | MEDLINE | ID: mdl-11097672
ABSTRACT
BACKGROUND AND

OBJECTIVES:

The vascular effects of local anesthetics are important determinants of their therapeutic activity. Drugs that vasoconstrict have the potential clinical advantages of limited systemic uptake and prolonged duration of effect. The aim of this study was to assess quantitatively the cutaneous vasoactivity of racemic bupivacaine and one of its enantiomers, levobupivacaine.

METHODS:

Four concentrations of each drug (0.1 mL each of 0.125%, 0.25%, 0.5%, and 0.75%), as well as normal saline, were injected intradermally into randomly assigned sites on the forearms of 10 volunteers. We measured skin blood perfusion using laser Doppler imaging before injection and at 2.5, 10, 20, 40, 60, and 90 minutes thereafter.

RESULTS:

Both drugs produced a rapid, dose-dependent increase in skin perfusion (P <.001). Saline also caused an increase in perfusion, although less sustained. By 40 minutes, most responses had returned to baseline levels. However, after this time, perfusion continued to decrease, below baseline, for both bupivacaine and levobupivacaine. The exception to this was 0.75% bupivacaine, the response to which was significantly higher than the same concentration of levobupivacaine over this later period (P <.05).

CONCLUSIONS:

Bupivacaine and levobupivacaine both have a biphasic effect on skin microvessels. The vasoconstriction observed after 40 minutes may occur when the quantity of drug remaining at the administration site has decreased to a lower level. The continued vasodilatation caused by bupivacaine is more difficult to interpret. The results suggest that these local anesthetics cause vasodilatation at high doses and vasoconstriction at lower, subclinical doses. This hypothesis and the clinical relevance of these effects warrant further investigation.
Assuntos
Buscar no Google
Base de dados: MEDLINE Assunto principal: Pele / Bupivacaína / Anestésicos Locais Tipo de estudo: Clinical_trials / Evaluation_studies Limite: Adult / Humans / Male / Middle aged Idioma: En Ano de publicação: 2000 Tipo de documento: Article
Buscar no Google
Base de dados: MEDLINE Assunto principal: Pele / Bupivacaína / Anestésicos Locais Tipo de estudo: Clinical_trials / Evaluation_studies Limite: Adult / Humans / Male / Middle aged Idioma: En Ano de publicação: 2000 Tipo de documento: Article